Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Drug and Alcohol Review · 2026
DOI: 10.1111/dar.70079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2026. Verfasst von M J Stowe und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Opiate Substitution Treatment, Patient Preference, Methadone. Die Arbeit nennt 71 Literaturangaben. Gefördert von: National Drug and Alcohol Research Centre, National Health and Medical Research Council, NIDA NIH HHS.
Abstract (Originalsprache)
Introduction
Opioid agonist therapies (OAT) reduce adverse outcomes of illicit opioid use, with individual preferences potentially improving treatment outcomes. We explored preferences for OAT and associated factors in a national sample of people with opioid dependence.
Methods
This cross‐sectional study recruited 400 participants (October 2020–April 2021) across Australia (excluding Tasmania) through snowball sampling. Participants completed an interviewer‐administered questionnaire on sociodemographic and drug use characteristics. Multivariable logistic regression assessed factors associated with methadone preference (vs. buprenorphine).
Results
Among all participants (median age 45, 41% female, 87% ever received OAT), 92% ( n = 366) indicated a preference for receiving OAT (vs. not receiving OAT) and 96% of those ( n = 352) preferred a particular type of OAT. Among 366 with a stated preference, 61% ( n = 216) preferred methadone and 39% ( n = 136) preferred buprenorphine. Among those preferring buprenorphine ( n = 136), 50% ( n = 68) preferred buprenorphine ± naloxone and 50% ( n = 68) preferred long‐acting injectable buprenorphine. Independent correlates of preferring methadone included past month heroin use (aOR 1.78, 95% CI 1.06–3.00) and non‐prescribed pharmaceutical opioid use (aOR 2.23, 95% CI 1.07, 4.95), and any prior receipt of methadone treatment (aOR 6.54, 95% CI 2.66, 17.91). Among those receiving OAT, a higher proportion of people currently receiving buprenorphine preferred their medication (61/66, 92%) compared to methadone recipients (180/235, 77%). Discussion and Conclusions Nearly all participants preferred OAT, mostly reflecting prior experiences, underscoring the need for expanded access to OAT in Australia. Given the multiple stated preferences, OAT options should include a variety of treatment options aligned with patient preferences, including expanded take‐home options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Kirby Institute, University of New South Wales, Sydney, Australia.
- Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
- National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
- National Drug Research Institute, Curtin University, Melbourne, Australia.
- Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney, Australia.
- Drug and Alcohol Services, Northern Sydney Local Health District, Sydney, Australia.
ORCID-Profile: M J Stowe, Jeremy Hayllar, Mark Daglish, Victoria Cock, Michael Christmass, Charles Henderson, Louisa Degenhardt, Jason Grebely
Förderung
- National Drug and Alcohol Research Centre
- National Health and Medical Research Council
- NIDA NIH HHS
- Kirby Institute
Zitieren
APA
Stowe, M. J., Conway, A., Altice, F. L., Colledge-Frisby, S., Read, P., Montebello, M., Whitton, G., Hayllar, J., Daglish, M., Cock, V., Christmass, M., Crawford, S., Henderson, C., Dore, G. J., Gough, C., Farrell, M., Degenhardt, L., & Grebely, J. (2026). Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids. Drug and Alcohol Review. https://doi.org/10.1111/dar.70079
Vancouver
Stowe MJ, Conway A, Altice FL, Colledge-Frisby S, Read P, Montebello M, et al. Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids. Drug and Alcohol Review. 2026. doi:10.1111/dar.70079
BibTeX
@article{Stowe2026,
author = {Stowe, M J and Conway, Anna and Altice, Frederick L and Colledge-Frisby, Samantha and Read, Phillip and Montebello, Mark and Whitton, Gilbert and Hayllar, Jeremy and Daglish, Mark and Cock, Victoria and Christmass, Michael and Crawford, Sione and Henderson, Charles and Dore, Gregory J and Gough, Chris and Farrell, Michael and Degenhardt, Louisa and Grebely, Jason},
title = {Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids},
journal = {Drug and Alcohol Review},
year = {2026},
doi = {10.1111/dar.70079}
}
EUVIMED